TransAct (NASDAQ: TACT) grows 2025 revenue 19% and guides to $55–$57M in 2026
Rhea-AI Filing Summary
TransAct Technologies reported preliminary results showing solid growth for 2025 and a much smaller loss. Net sales rose to
The company cut its net loss to
Positive
- Revenue growth and mix improvement: 2025 net sales rose to $51.5M from $43.4M (19% growth), with BOHA! terminal units up 36% to 7,317 and recurring FST revenue up 14%, supporting the shift toward software and higher-margin, subscription-like revenue.
- Sharp loss reduction and EBITDA turnaround: Net loss narrowed to $1.2M from $9.9M, while adjusted EBITDA improved from a $1.5M loss to $1.2M positive, indicating better operating leverage and cost control.
Negative
- Business remains loss-making on a GAAP basis: Despite significant improvement, the company still reported a 2025 GAAP net loss of $1.2M and negative EBITDA for Q4, underscoring that full, sustainable profitability is not yet achieved.
Insights
TransAct delivers strong 2025 growth, sharply narrows losses, and targets further revenue gains in 2026.
TransAct Technologies posted preliminary 2025 net sales of
Profitability trends improved meaningfully. Net loss shrank to
For
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission file number) | (I.R.S. employer identification no.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area
code:
(Former Name or Former Address, if Changed Since Last Report): Not applicable
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth
Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 Results of Operations and Financial Condition.
The following information is being furnished pursuant to Item 2.02 “Results of Operations and Financial Condition” of Form 8-K. Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
On March 10, 2026, TransAct Technologies Incorporated issued a press release announcing its financial results for the quarter and year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
| Exhibit | Description | |
| 99.1 | Press Release dated March 10, 2026 of TransAct Technologies Incorporated | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| TRANSACT TECHNOLOGIES INCORPORATED | ||
| By: | /s/ Steven A. DeMartino | |
| Steven A. DeMartino | ||
| President, Chief Financial Officer, Treasurer and Secretary | ||
Date: March 10, 2026
Exhibit 99.1
TransAct Technologies Reports
Preliminary Fourth Quarter and Full Year 2025 Financial Results
Sold 1,434 Terminals in the Fourth Quarter and 7,317 in Full Year 2025, Representing 36% Full Year-over-Full Year Growth
Welcomed New Chief Marketing Officer, Dana Loof, in the Fourth Quarter
Full Year 2025 Net Sales up 19% and Recurring FST Revenue up 14% Year-over-Year
Guides to 2026 Revenue of $55-$57 Million, Driven by Anticipated High Margin Software Sales
Hamden, CT –March 10, 2026 – TransAct Technologies Incorporated (Nasdaq: TACT) (“TransAct” or the “Company”), a global leader in software-driven technology and printing solutions for high-growth markets, today reported preliminary results for the fourth quarter and full year ended December 31, 2025.
"We delivered a strong fourth quarter and full year, with BOHA! terminal sales up 36% to 7,317 units for the year and record label revenue in Q4. These results reflect meaningful progress in our go-to-market execution and growing customer adoption of our food service technology (FST) solutions," said John Dillon, Chief Executive Officer of TransAct. “With all rights to the BOHA! software now in hand and full ownership of all associated modifications, innovations and licensing models now secured, we believe that software is unequivocally our growth engine going forward. We're positioned to accelerate innovation, introduce new applications, and drive margin expansion through recurring revenue. Our casino and gaming market also performed well and continues to provide steady cash flow to fund these FST investments. We remain committed to fiscal discipline as we pursue this software-driven transformation to create long-term value for stockholders."
Fourth Quarter 2025 Financial Highlights
| • | Net Sales: Net sales for the fourth quarter of 2025 were $11.5 million, up 12% compared to $10.2 million for the fourth quarter of 2024 as a result of stronger sales in both our casino and gaming and FST markets. |
| • | FST Recurring Revenue: FST recurring revenue for the fourth quarter of 2025 was $3.4 million, which represents an increase of 24% compared to $2.7 million for the fourth quarter of 2024. |
| • | Gross Profit: Gross profit for the fourth quarter of 2025 was $5.4 million, resulting in gross margin of 47.6%, compared to gross profit of $4.5 million for the fourth quarter of 2024, which delivered a 44.2% gross margin. |
| • | Operating loss: Operating loss for the fourth quarter of 2025 was $(1.2) million, compared to operating income of $14 thousand for the third quarter of 2025 and an operating loss of $(1.1) million for the fourth quarter of 2024. |
| • | Net (loss) income: Net loss for the fourth quarter of 2025 was $(1.1) million, or $(0.11) per diluted share, based on 10.1 million weighted average common shares outstanding. This compares sequentially to net income for the third quarter of 2025 of $15 thousand, or $(0.00) per diluted share and a net loss for the fourth quarter of 2024 of $(8.0) million, or $(0.79) per diluted share, based on 10.0 million weighted average common shares outstanding. The net loss for the fourth quarter of 2024 includes a $7.3 million non-cash charge to income tax expense to record a full valuation allowance on our deferred tax assets. |
| • | Adjusted net loss: Adjusted net loss for the fourth quarter of 2025 was $(1.1) million, or $(0.11) per diluted share, based on 10.1 million weighted average common shares outstanding. This compares to an adjusted net loss for the fourth quarter of 2024 of $(644) thousand, or $(0.06) per diluted share, based on 10.0 million weighted average common shares outstanding. These numbers for the fourth quarter of 2024 exclude the effect of a $7.3 million non-cash charge, or $(0.73) per share, to income tax expense to record a full valuation allowance on our deferred tax assets. |
| • | EBITDA: EBITDA was $(1.0) million for the fourth quarter of 2025, compared to $(1.0) million for the fourth quarter of 2024. |
| • | Adjusted EBITDA: Adjusted EBITDA was $(499) thousand for the fourth quarter of 2025, compared to$(705) thousand for the fourth quarter of 2024. |
Full Year 2025 Financial Highlights
| • | Net Sales: Net sales for the full year 2025 were $51.5 million, up 19% compared to $43.4 million for the full year 2024. |
| • | FST Recurring Revenue: FST recurring revenue for the full year 2025 was $12.3 million, up 14% compared to $10.8 million for the full year 2024. |
| • | Gross Profit: Gross profit for the full year 2025 was $25.0 million, resulting in gross margin of 48.6%, compared to gross profit of $21.5 million for the full year 2024, which delivered a 49.5% gross margin. |
| • | Operating loss: Operating loss for the full year 2025 was $(1.4) million, compared to an operating loss of $(3.6) million for the full year 2024. |
| • | Net loss: Net loss for the full year 2025 was $(1.2) million, or $(0.12) per diluted share, based on 10.1 million weighted average common shares outstanding. This compares to a net loss of $(9.9) million for the full year 2024, or $(0.99) per diluted share, based on 10.0 million weighted average common shares outstanding. The net loss for the full year 2024 includes a $7.3 million non-cash charge to income tax expense to record a full valuation allowance on our deferred tax assets. |
| • | Adjusted net loss: Adjusted net loss for the full year 2025 was $(1.2) million, or $(0.12) per diluted share, based on 10.1 million weighted average common shares outstanding. This compares to an adjusted net loss for the full year 2024 of $(2.6) million, or $(0.26) per diluted share, based on 10.0 million weighted average common shares outstanding. These numbers for the full year 2024 exclude the effect of a $7.3 million non-cash charge, or $(0.73) per share, to income tax expense to record a full valuation allowance on our deferred tax assets. |
| • | EBITDA: EBITDA was $(610) thousand for the full year 2025, compared to $(2.7) million for the full year 2024. |
| • | Adjusted EBITDA: Adjusted EBITDA was $1.2 million for the full year 2025, compared to $(1.5) million for the full year 2024. |
2026 Financial Outlook
| • | Net Sales: The Company expects full year 2026 net sales of between $55 million and $57 million. |
| • | Adjusted EBITDA: The Company expects full year 2026 adjusted EBITDA to be between $800 thousand and $1.5 million. |
Our outlook for non-GAAP adjusted EBITDA is presented only on a non-GAAP basis because not all of the information necessary for a quantitative reconciliation of this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure is available without unreasonable effort, primarily due to uncertainties relating to the occurrence or amount of the adjustments that may arise in the future. If one or more of the currently unavailable items is applicable, some items could be material, individually or in the aggregate, to GAAP reported results.
2025 Fourth Quarter and Full Year Conference Call and Webcast
TransAct is hosting a conference call and webcast today, March 10, 2026, beginning at 4:30 p.m. ET to discuss the Company’s preliminary fourth quarter and full year 2025 results and other matters. Both the call and the webcast are open to the general public. The conference call number is 877-704-4453 and the conference ID number is 13759103. Please call ten minutes prior to the presentation to ensure that you are connected.
Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “About Us” followed by “Investor Relations,” then select “News & Events” followed by “Events & Presentations”), or directly at https://transacttech.gcs-web.com/events/event-details/transact-technologies-fourth-quarter-2025-earnings-call. Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these measures are helpful to investors and others in assessing the ongoing nature of what the Company’s management views as TransAct’s core operations. EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. The Company believes that these non-GAAP financial measures provide relevant and useful information to an investor evaluating the Company’s operating performance because these measures are: (i) widely used by investors to measure a company’s operating performance without regard to items that do not reflect the Company’s ongoing operations and are excluded from the calculation of such measures; (ii) used as financial measurements by lenders and other parties to evaluate creditworthiness; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting and assessing financial performance. Adjusted net (loss) income and adjusted net (loss) income per diluted share provide the Company with an understanding of the results of the primary operations of the business by excluding the effects of items such as the $7.3 million non-cash charge to income tax expense in the fourth quarter of 2024 to record a full valuation allowance on the Company’s deferred tax assets that do not reflect the ordinary earnings of the Company’s operations. The Company uses these measures to evaluate period-over-period operating performance because the Company believes this provides a more comparable measure of the Company’s continuing business, as these measures adjust for the special or discrete items that are not reflective of the normal results of the business. The presentation of this non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.
EBITDA is defined as net (loss) income before net interest income (expense), income taxes, depreciation, and amortization. A reconciliation of EBITDA to net loss, the most comparable GAAP financial measure, can be found attached to this release.
Adjusted EBITDA is defined as net (loss) income before net interest income (expense), income taxes, depreciation and amortization and is adjusted for (1) share-based compensation expense and (2) any other items, when they occur, that we believe do not reflect the ordinary earnings of the Company’s ongoing business. The Company adjusts EBITDA for share-based compensation because the Company considers share-based compensation expense to be a non-cash expense similar to depreciation and amortization. A reconciliation of adjusted EBITDA to net loss, the most comparable GAAP financial measure, can be found attached to this release.
Adjusted net loss is defined as net loss adjusted for (1) significant discrete tax events such as the $7.3 million non-cash charge to income tax expense in the fourth quarter of 2024 to record a full valuation allowance on the Company’s deferred tax assets and (2) any other items, when they occur, that we believe do not reflect the ordinary earnings of the Company’s ongoing business. A reconciliation of adjusted net loss, the most comparable GAAP financial measure, can be found attached to this release.
Adjusted net loss per diluted share is defined as adjusted net loss divided by diluted shares outstanding. A reconciliation of adjusted net loss per diluted share to net loss per diluted share, the most comparable GAAP financial measure, can be found attached to this release.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a global leader in developing and selling software-driven technology and printing solutions for high-growth markets including food service, casino and gaming, and POS automation. The Company’s solutions are designed from the ground up based on customer requirements and are sold under the BOHA!®, AccuDate®, EPICENTRAL®, Epic and Ithaca® brands. TransAct has sold over 4.0 million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts, labels and accessories to support its installed product base. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.
©2026 TRANSACT Technologies Incorporated. All rights reserved. TransAct®, BOHA! ®, AccuDate®, Epic Edge®, EPICENTRAL® and Ithaca® are trademarks of TransAct Technologies Incorporated.
Cautionary Statement Regarding Preliminary Financial Information
The Company has prepared the preliminary financial information set forth below on a materially consistent basis with its historical financial information and in good faith based upon its internal reporting as of and for the three months and full year ended December 31, 2025. This financial information is preliminary and is thus inherently uncertain and subject to change as the Company finalizes its financial results and related review for the three months and audit for the full year ended December 31, 2025. During the preparation of the Company’s consolidated financial statements and related notes as of and for the three months and full year ended December 31, 2025, the Company may identify items that could cause its final reported results to be materially different from the preliminary financial information set forth above. As a result, there can be no assurance that the Company’s final results for these periods will not differ from the preliminary financial information.
This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. In addition, this preliminary financial information is not necessarily indicative of the results to be achieved for any future period.
Forward-Looking Statements
Certain statements included in this press release are forward-looking statements within the meaning of the U.S. federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements are any statements other than statements of historical fact. Forward-looking statements represent current views about possible future events and are often identified by the use of forward-looking terminology, such as ”may”, ”will”, ”could”, ”expect”, ”intend”, ”estimate”, “anticipate”, ”believe”, ”project”, ”plan”, ”predict”, ”design” or ”continue”, or the negative thereof, or other similar words. Forward-looking statements are subject to certain risks, uncertainties and assumptions. In the event that one or more of such risks or uncertainties materialize, or one or more underlying assumptions prove incorrect, actual results may differ materially from those expressed or implied by the forward-looking statements. Important factors and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include, but are not limited to, the following: the adverse effects of current economic conditions on our business, operations, financial condition, results of operations and capital resources; our ability to achieve the anticipated benefits of our acquisition of a licensed copy of the source code for the BOHA! software and risks to our reputation and business relating to the source code transition; our ability to successfully transition the BOHA! source code to our platform and systems and, until such transition is complete, our continued reliance on third parties to host and support our FST offerings; difficulties or delays in manufacturing or delivery of inventory or other supply chain disruptions; our dependence on a single contract manufacturer for the assembly of a large portion of our products in Asia; the imposition of additional duties, tariffs, quotas, taxes, trade barriers, capital flow restrictions and other charges on imports and exports by the United States or the governments of the countries in which we or our manufacturers and suppliers operate; the Russia/Ukraine and Middle East conflicts; inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting manufacturing requirements due to volatile economic conditions; price increases, decreased availability of third-party component parts or raw materials at reasonable prices, price wars or significant pricing pressures affecting the Company’s products in the United States or abroad; increased product costs or reduced customer demand for our products in the United States or abroad, including as a result of trade wars, tariffs or other trade actions; our ability to successfully develop new products that garner customer acceptance and generate sales, both domestically and internationally, in the face of substantial competition; any system outages, interruptions or other disruptions to our software applications, including as a result of unexpected errors or mistakes in connection with over-the-air updates; our ability to successfully grow our business in the food service technology market; renewal rates for our subscription-based products; risks associated with the pursuit of strategic initiatives and business growth; our dependence on significant suppliers; our ability to recruit and retain quality employees; our dependence on third parties for sales outside the United States; marketplace acceptance of new products; risks associated with foreign operations; political and policy uncertainties and any adverse economic impacts resulting from such uncertainties; our ability to protect intellectual property; exchange rate fluctuations; the availability of needed financing on acceptable terms or at all; volatility of, and decreases in, trading prices of our common stock; and other risk factors identified and discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and other reports filed with the Securities and Exchange Commission. We caution readers not to place undue reliance on forward-looking statements, which speak only as of the date of this release. We undertake no obligation to publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or other factors, except where we are expressly required to do so by applicable law.
# # #
Investor Contact:
Ryan Gardella
ICR, Inc.
Ryan.Gardella@icrinc.com
- Financial tables follow-
TRANSACT TECHNOLOGIES INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Preliminary and Unaudited)
| Three months ended | Year ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (In thousands, except per share data) | ||||||||||||||||
| Net sales | $ | 11,453 | $ | 10,231 | $ | 51,480 | $ | 43,384 | ||||||||
| Cost of sales | 6,005 | 5,710 | 26,465 | 21,902 | ||||||||||||
| Gross profit | 5,448 | 4,521 | 25,015 | 21,482 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Engineering, design and product development | 1,685 | 1,572 | 6,701 | 6,977 | ||||||||||||
| Selling and marketing | 2,154 | 2,035 | 8,433 | 8,195 | ||||||||||||
| General and administrative | 2,765 | 1,964 | 11,296 | 9,936 | ||||||||||||
| 6,604 | 5,571 | 26,430 | 25,108 | |||||||||||||
| Operating loss | (1,156 | ) | (1,050 | ) | (1,415 | ) | (3,626 | ) | ||||||||
| Interest and other income (expense): | ||||||||||||||||
| Interest, net | 75 | 31 | 198 | 147 | ||||||||||||
| Other, net | (10 | ) | (132 | ) | 133 | (89 | ) | |||||||||
| 65 | (101 | ) | 331 | 58 | ||||||||||||
| Loss before income taxes | (1,091 | ) | (1,151 | ) | (1,084 | ) | (3,568 | ) | ||||||||
| Income tax expense | (40 | ) | (6,806 | ) | (156 | ) | (6,295 | ) | ||||||||
| Net loss | $ | (1,131 | ) | $ | (7,957 | ) | $ | (1,240 | ) | $ | (9,863 | ) | ||||
| Net loss per common share: | ||||||||||||||||
| Basic | $ | (0.11 | ) | $ | (0.79 | ) | $ | (0.12 | ) | $ | (0.99 | ) | ||||
| Diluted | $ | (0.11 | ) | $ | (0.79 | ) | $ | (0.12 | ) | $ | (0.99 | ) | ||||
| Shares used in per share calculation: | ||||||||||||||||
| Basic | 10,118 | 10,014 | 10,087 | 9,997 | ||||||||||||
| Diluted | 10,118 | 10,014 | 10,087 | 9,997 | ||||||||||||
SUPPLEMENTAL INFORMATION – SALES BY MARKET:
(Preliminary and Unaudited)
| Three months ended | Year ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (In thousands) | ||||||||||||||||
| Food service technology | $ | 4,808 | $ | 4,302 | $ | 19,318 | $ | 16,101 | ||||||||
| POS automation | 606 | 411 | 2,213 | 3,361 | ||||||||||||
| Casino and gaming | 5,381 | 4,759 | 26,873 | 20,348 | ||||||||||||
| TransAct Services Group | 658 | 759 | 3,076 | 3,574 | ||||||||||||
| Total net sales | $ | 11,453 | $ | 10,231 | $ | 51,480 | $ | 43,384 | ||||||||
TRANSACT TECHNOLOGIES INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
(Preliminary and Unaudited)
| December 31, | December 31, | |||||||
| 2025 | 2024 | |||||||
| (In thousands) | ||||||||
| Assets: | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 20,433 | $ | 14,394 | ||||
| Accounts receivable, net | 6,364 | 6,507 | ||||||
| Inventories | 10,858 | 16,161 | ||||||
| Prepaid income taxes | 399 | 401 | ||||||
| Other current assets | 754 | 899 | ||||||
| Total current assets | 38,808 | 38,362 | ||||||
| Fixed assets, net | 1,243 | 1,818 | ||||||
| Right-of-use assets, net | 557 | 1,141 | ||||||
| Goodwill | 2,621 | 2,621 | ||||||
| Intangible assets, net | 1,503 | - | ||||||
| Other assets | 37 | 92 | ||||||
| 5,961 | 5,672 | |||||||
| Total assets | $ | 44,769 | $ | 44,034 | ||||
| Liabilities and Shareholders’ Equity: | ||||||||
| Current liabilities: | ||||||||
| Revolving loan payable | $ | 3,000 | $ | 3,000 | ||||
| Accounts payable | 3,539 | 4,569 | ||||||
| Accrued liabilities | 4,763 | 3,253 | ||||||
| Lease liabilities | 346 | 955 | ||||||
| Deferred revenue | 1,400 | 1,107 | ||||||
| Total current liabilities | 13,048 | 12,884 | ||||||
| Deferred revenue, net of current portion | 355 | 246 | ||||||
| Lease liabilities, net of current portion | 215 | 231 | ||||||
| Other liabilities | 35 | 40 | ||||||
| 605 | 517 | |||||||
| Total liabilities | 13,653 | 13,401 | ||||||
| Shareholders’ equity: | ||||||||
| Common stock | 141 | 141 | ||||||
| Additional paid-in capital | 59,824 | 58,141 | ||||||
| Retained earnings | 3,275 | 4,515 | ||||||
| Accumulated other comprehensive loss, net of tax | (14 | ) | (54 | ) | ||||
| Treasury stock, at cost | (32,110 | ) | (32,110 | ) | ||||
| Total shareholders’ equity | 31,116 | 30,633 | ||||||
| Total liabilities and shareholders’ equity | $ | 44,769 | $ | 44,034 | ||||
TRANSACT TECHNOLOGIES INCORPORATED
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts)
| Three months ended December 31, 2025 | ||||||||||||
| Reported | Adjustments(1) | Adjusted Non-GAAP | ||||||||||
| Operating expenses | $ | 6,604 | $ | - | $ | 6,604 | ||||||
| % of net sales | 57.7 | % | 57.7 | % | ||||||||
| Operating loss | (1,156 | ) | - | (1,156 | ) | |||||||
| % of net sales | (10.1 | )% | (10.1 | )% | ||||||||
| Interest and other income | 65 | - | 65 | |||||||||
| Loss before income taxes | (1,091 | ) | - | (1,091 | ) | |||||||
| Income tax expense | (40 | ) | - | (40 | ) | |||||||
| Net loss | (1,131 | ) | - | (1,131 | ) | |||||||
| Net loss per common share: | ||||||||||||
| Basic | $ | (0.11 | ) | $ | - | $ | (0.11 | ) | ||||
| Diluted | $ | (0.11 | ) | $ | - | $ | (0.11 | ) | ||||
| (1) | No adjustments. |
| Three months ended December 31, 2024 | ||||||||||||
| Reported | Adjustments(2) | Adjusted Non-GAAP | ||||||||||
| Operating expenses | $ | 5,571 | $ | - | $ | 5,571 | ||||||
| % of net sales | 54.5 | % | 54.5 | % | ||||||||
| Operating loss | (1,050 | ) | - | (1,050 | ) | |||||||
| % of net sales | (10.3 | )% | (10.3 | )% | ||||||||
| Interest and other expense | (101 | ) | - | (101 | ) | |||||||
| Loss before income taxes | (1,151 | ) | - | (1,151 | ) | |||||||
| Income tax (expense) benefit | (6,806 | ) | 7,313 | 507 | ||||||||
| Net loss | (7,957 | ) | 7,313 | (644 | ) | |||||||
| Net loss per common share: | ||||||||||||
| Basic | $ | (0.79 | ) | $ | 0.73 | $ | (0.06 | ) | ||||
| Diluted | $ | (0.79 | ) | $ | 0.73 | $ | (0.06 | ) | ||||
| (2) | Adjustment includes a $7.3 million non-cash charge to income tax expense in the fourth quarter of 2024 to record a full valuation allowance on the Company’s deferred tax assets. |
TRANSACT TECHNOLOGIES INCORPORATED
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts)
| Year ended December 31, 2025 | ||||||||||||
| Reported | Adjustments(3) | Adjusted Non-GAAP | ||||||||||
| Operating expenses | $ | 26,430 | $ | - | $ | 26,430 | ||||||
| % of net sales | 51.3 | % | 51.3 | % | ||||||||
| Operating loss | (1,415 | ) | - | (1,415 | ) | |||||||
| % of net sales | (2.7 | )% | (2.7 | )% | ||||||||
| Interest and other income | 331 | - | 331 | |||||||||
| Loss before income taxes | (1,084 | ) | - | (1,084 | ) | |||||||
| Income tax expense | (156 | ) | - | (156 | ) | |||||||
| Net loss | (1,240 | ) | - | (1,240 | ) | |||||||
| Net loss per common share: | ||||||||||||
| Basic | $ | (0.12 | ) | $ | - | $ | (0.12 | ) | ||||
| Diluted | $ | (0.12 | ) | $ | - | $ | (0.12 | ) | ||||
| (3) | No adjustments. |
| Year ended December 31, 2024 | ||||||||||||
| Reported | Adjustments(4) | Adjusted Non-GAAP | ||||||||||
| Operating expenses | $ | 25,108 | $ | - | $ | 25,108 | ||||||
| % of net sales | 57.9 | % | 57.9 | % | ||||||||
| Operating loss | (3,626 | ) | - | (3,626 | ) | |||||||
| % of net sales | (8.4 | )% | (8.4 | )% | ||||||||
| Interest and other income | 58 | - | 58 | |||||||||
| Loss before income taxes | (3,568 | ) | - | (3,568 | ) | |||||||
| Income tax (expense) benefit | (6,295 | ) | 7,313 | 1,018 | ||||||||
| Net loss | (9,863 | ) | 7,313 | (2,550 | ) | |||||||
| Net loss per common share: | ||||||||||||
| Basic | $ | (0.99 | ) | $ | 0.73 | $ | (0.26 | ) | ||||
| Diluted | $ | (0.99 | ) | $ | 0.73 | $ | (0.26 | ) | ||||
| (4) | Adjustment includes a $7.3 million non-cash charge to income tax expense in the fourth quarter of 2024 to record a full valuation allowance on the Company’s deferred tax assets. |
TRANSACT TECHNOLOGIES INCORPORATED
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA
NON-GAAP FINANCIAL MEASURES
(Preliminary and Unaudited)
| Three months ended | Year ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (In thousands) | ||||||||||||||||
| Net loss | $ | (1,131 | ) | $ | (7,957 | ) | $ | (1,240 | ) | $ | (9,863 | ) | ||||
| Interest income, net | (75 | ) | (31 | ) | (198 | ) | (147 | ) | ||||||||
| Income tax expense | 40 | 6,806 | 156 | 6,295 | ||||||||||||
| Depreciation and amortization | 165 | 193 | 672 | 1,037 | ||||||||||||
| EBITDA | (1,001 | ) | (989 | ) | (610 | ) | (2,678 | ) | ||||||||
| Share-based compensation expense | 502 | 284 | 1,802 | 1,157 | ||||||||||||
| Adjusted EBITDA | $ | (499 | ) | $ | (705 | ) | $ | 1,192 | $ | (1,521 | ) | |||||
FAQ
How did TransAct Technologies (TACT) perform financially in 2025?
What drove TransAct Technologies’ revenue growth in 2025?
Did TransAct Technologies improve profitability in 2025?
What revenue guidance did TransAct Technologies give for 2026?
How did TransAct’s different markets perform in 2025?
What is TransAct Technologies’ cash and balance sheet position?
Filing Exhibits & Attachments
4 documentsPress Releases
